Bharat Parenterals Ltd banner
B

Bharat Parenterals Ltd
BSE:541096

Watchlist Manager
Bharat Parenterals Ltd
BSE:541096
Watchlist
Price: 1 213 INR 2.3% Market Closed
Market Cap: ₹8.4B

Bharat Parenterals Ltd
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Bharat Parenterals Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
B
Bharat Parenterals Ltd
BSE:541096
Total Current Liabilities
₹1.3B
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Current Liabilities
₹151B
CAGR 3-Years
24%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Current Liabilities
₹63B
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
5%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Current Liabilities
₹234.2B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
5%
Lupin Ltd
NSE:LUPIN
Total Current Liabilities
₹108.2B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
9%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Current Liabilities
₹44.4B
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
3%
No Stocks Found

Bharat Parenterals Ltd
Glance View

Market Cap
8.4B INR
Industry
Pharmaceuticals

Bharat Parenterals Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2018-03-21. The firm is engaged in research, development, manufacturing, marketing, sourcing and distribution of pharmaceutical products. The firm offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other.

BPLPHARMA Intrinsic Value
671.51 INR
Overvaluation 45%
Intrinsic Value
Price ₹1 213
B

See Also

What is Bharat Parenterals Ltd's Total Current Liabilities?
Total Current Liabilities
1.3B INR

Based on the financial report for Dec 31, 2025, Bharat Parenterals Ltd's Total Current Liabilities amounts to 1.3B INR.

What is Bharat Parenterals Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
18%

Over the last year, the Total Current Liabilities growth was -14%. The average annual Total Current Liabilities growth rates for Bharat Parenterals Ltd have been 12% over the past three years , 18% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett